Zhejiang Xianju Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2022: 6.02%

Zhejiang Xianju Pharmaceutical Co Ltd (002332) has an Asset Resilience Ratio of 6.02% as of September 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Zhejiang Xianju Pharmaceutical Co Ltd (002332) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥404.51 Million

≈ $59.19 Million USD Cash + Short-term Investments

Total Assets

CN¥6.72 Billion

≈ $982.93 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2021)

This chart shows how Zhejiang Xianju Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See 002332 net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Zhejiang Xianju Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002332 market cap.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥404.51 Million	6.02%
Total Liquid Assets	CN¥404.51 Million	6.02%

Asset Resilience Insights

Limited Liquidity: Zhejiang Xianju Pharmaceutical Co Ltd maintains only 6.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Zhejiang Xianju Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhejiang Xianju Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Daihan Pharmaceutical Co.Ltd KQ:023910	Drug Manufacturers - Specialty & Generic	11.95%
Aurobindo Pharma Limited NSE:AUROPHARMA	Drug Manufacturers - Specialty & Generic	16.92%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd SHE:000999	Drug Manufacturers - Specialty & Generic	5.22%
Ningbo Menovo Pharm Co Ltd SHG:603538	Drug Manufacturers - Specialty & Generic	2.69%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Hainan Honz Pharmaceutical Co SHE:300086	Drug Manufacturers - Specialty & Generic	0.27%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd SHE:300534	Drug Manufacturers - Specialty & Generic	-8.30%

Annual Asset Resilience Ratio for Zhejiang Xianju Pharmaceutical Co Ltd (2015–2021)

The table below shows the annual Asset Resilience Ratio data for Zhejiang Xianju Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2021-12-31	7.45%	CN¥500.64 Million ≈ $73.26 Million	CN¥6.72 Billion ≈ $983.82 Million	+0.13pp
2020-12-31	7.32%	CN¥500.44 Million ≈ $73.23 Million	CN¥6.84 Billion ≈ $1.00 Billion	+4.37pp
2017-12-31	2.95%	CN¥151.50 Million ≈ $22.17 Million	CN¥5.13 Billion ≈ $751.35 Million	-5.34pp
2016-12-31	8.29%	CN¥300.00 Million ≈ $43.90 Million	CN¥3.62 Billion ≈ $529.83 Million	-1.89pp
2015-12-31	10.18%	CN¥350.00 Million ≈ $51.22 Million	CN¥3.44 Billion ≈ $503.23 Million	--

pp = percentage points

About Zhejiang Xianju Pharmaceutical Co Ltd

SHE:002332 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.27 Billion

CN¥8.68 Billion CNY

Market Cap Rank

#8074 Global

#2028 in China

Share Price

CN¥8.77

Change (1 day)

-0.45%

52-Week Range

CN¥8.59 - CN¥11.58

All Time High

CN¥16.51